A feasibility study of postoperative chemotherapy with S-1 and cisplatin (CDDP) for gastric carcinoma (CCOG0703)

Gastric Cancer

Volumn 13, Issue 3, 2010, Pages 197-203

  Kodera, Yasuhiro ^a   Ishiyama, Akiharu ^b   Yoshikawa, Takaki ^c   Kinoshita, Takashi ^d   Ito, Seiji ^e   Yokoyama, Hiroyuki ^f   Mochizuki, Yoshinari ^f   Ito, Hiroaki ^g   Tsuburaya, Akira ^c   Sakamoto, Junichi ^a   Nakao, Akimasa ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Okazaki City Hospital   (Japan)

^c KANAGAWA CANCER CENTER   (Japan)

^d Yokkaichi Municipal Hospital   (Japan)

^e AICHI CANCER CENTER HOSPITAL   (Japan)

^f Komaki Municipal Hospital   (Japan)

^g Tajimi Hospital   (Japan)

Author keywords

CDDP; Gastric cancer; Metastasis; Relative dose intensity; S 1

Indexed keywords

5 CHLORO 2,4 DIHYDROXYPYRIDINE PLUS OXONATE POTASSIUM PLUS TEGAFUR; CISPLATIN;

ADULT; AGED; ANEMIA; ANOREXIA; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DISTANT METASTASIS; DOSE RESPONSE; DRUG DOSE REDUCTION; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEASIBILITY STUDY; FEMALE; GASTRECTOMY; HUMAN; LEUKOPENIA; LYMPH NODE METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUTROPENIA; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PERITONEUM METASTASIS; PIGMENT DISORDER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RECURRENT CANCER; SIDE EFFECT; STOMACH CARCINOMA; STOMATITIS; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT REFUSAL; VOMITING;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; CISPLATIN; DISEASE PROGRESSION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG COMBINATIONS; FEASIBILITY STUDIES; FEMALE; GASTRECTOMY; HUMANS; JAPAN; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; OXONIC ACID; POSTOPERATIVE CARE; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TEGAFUR; TIME FACTORS; TREATMENT OUTCOME;

EID: 77957967977     PISSN: 14363291     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10120-010-0559-y     Document Type: Article

References (25)

1. P. Pisani D. Parkin F. Bray J. Ferlay 1999 Estimates of the worldwide mortality from 25 cancers in 1990 Int J Cancer 83 18 29 1:STN:280: DyaK1MzotVaiuw%3D%3D 10.1002/(SICI)1097-0215(19990924) 83:1<18::AID- IJC5>3.0.CO;2-M 10449602 (Pubitemid 29409471)
2. J. Macdonald S. Smalley J. Benedetti S.A. Hundahl N.C. Estes G.N. Stemmermann, et al. 2001 Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction N Engl J Med 345 725 730 1:STN:280:DC%2BD3Mvps1Cqug%3D%3D 10.1056/NEJMoa010187 11547741
3. D. Cunningham W. Allum S. Stenning J.N. Thompson C.J. Van de Velde M. Nicolson, et al. 2006 Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer N Engl J Med 355 11 20 1:CAS:528: DC%2BD28Xms1Chsrw%3D 10.1056/NEJMoa055531 16822992
4. S. Sakuramoto M. Sasako T. Yamaguchi T. Kinoshita M. Fujii A. Nashimoto, et al. 2007 Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810 1820 1:CAS:528:DC%2BD2sXht1Kit7bI 10.1056/NEJMoa072252 17978289 (Pubitemid 350044801)
5. W. Koizumi M. Kurihara S. Nakano K. Hasegawa 2000 Phase II study of S-1, a novel oral derivative of 5-fluorouracil, in advanced gastric cancer. For the S-1 Cooperative Gastric Cancer Study Group Oncology 58 191 197 1:CAS:528:DC%2BD3cXjvVeitr4%3D 10.1159/000012099 10765119
6. Y. Sakata A. Ohtsu N. Horikoshi K. Sugimachi Y. Mitachi T. Taguchi 1998 Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur-0.4 M gimestat-1 M otastat potassium) in advanced gastric cancer patients Eur J Cancer 34 1715 1720 1:CAS:528:DyaK1cXntlShurw%3D 10.1016/S0959-8049(98)00211-1 9893658 (Pubitemid 28474225)
7. W. Koizumi S. Tanabe K. Saigenji A. Ohtsu N. Boku F. Nagashima, et al. 2003 Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancer Br J Cancer 89 2207 2212 1:CAS:528:DC%2BD3sXpvVShtbc%3D 10.1038/sj.bjc.6601413 14676796 (Pubitemid 38168001)
8. W. Koizumi H. Narahara T. Hara A. Takagane T. Akiya M. Takagi, et al. 2008 S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215 221 1:CAS:528:DC%2BD1cXivVaqtb4%3D 10.1016/S1470-2045(08)70035-4 18282805
9. Y. Kodera 2008 Disseminated cancer cells in the peritoneal cavity: what can we do when we detect them? Gastric Cancer 11 192 193 10.1007/s10120-008- 0490-7 19132479
10. S. Nakagawa A. Nashimoto H. Yabusaki 2007 Role of staging laparoscopy with peritoneal lavage cytology in the treatment of locally advanced gastric cancer Gastric Cancer 10 29 34 1:CAS:528:DC%2BD2sXisVejuro%3D 10.1007/s10120-006-0406-3 17334715 (Pubitemid 46356259)
11. T. Aiko M. Sasako 1998 The new Japanese classification of gastric carcinoma: points to be revised Gastric Cancer 1 25 30 10.1007/s101200050052 11957041
12. K. Maruyama M. Kaminishi K. Hayashi Y. Isobe I. Honda H. Katai, et al. 2006 Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry Gastric Cancer 9 51 66 10.1007/s10120-006-0370-y 16767357
13. K. Fujitani H. Yang Y. Kurokawa D.J. Park T. Tsujinaka B.J. Park, et al. 2008 Randomized controlled trial comparing gastrectomy plus chemotherapy with chemotherapy alone in advanced gastric cancer with a single non-curable factor: Japan Clinical Oncology Group Study JCOG 0705 and Korea Gastric Cancer Association Study KGCA01 Jpn J Clin Oncol 38 504 506 10.1093/jjco/hyn058 18617536
14. T. Yamanaka S. Matsumoto S. Teramukai R. Ishiwata Y. Nagai M. Fukushima 2007 Analysis of risk factors for severe adverse effects of oral 5-fluorouracil S-1 in patients with advanced gastric cancer Gastric Cancer 10 129 134 1:CAS:528:DC%2BD2sXms1yku7g%3D 10.1007/s10120-007-0422-y 17577624 (Pubitemid 46955943)
15. T. Kinoshita A. Nashimoto Y. Yamamura T. Okamura M. Sasako J. Sakamoto, et al. 2004 Feasibility study of adjuvant chemotherapy with S-1 (TS-1; tegafur, gimeracil, oteracil potassium) for gastric cancer Gastric Cancer 7 104 109 1:CAS:528:DC%2BD2cXlt1Gluro%3D 10.1007/s10120-004-0278-3 15224197
16. Y. Kodera S. Ito Y. Mochizuki K. Kondo K. Koshikawa N. Suzuki, et al. 2009 A phase II study of radical surgery followed by postoperative chemotherapy with S-1 for gastric carcinoma with free cancer cells in the peritoneal cavity (CCOG0301 study) Eur J Surg Oncol 35 1158 1163 1:STN:280:DC%2BD1MnptlSmtg%3D%3D 19328643
17. N. Uedo H. Narahara R. Ishihara H. Takiuchi M. Goto K. Fjitani, et al. 2007 Phase II study of a combination of irinotecan and S-1 in patients with advanced gastric cancer (OGSG0002) Oncology 73 65 71 1:CAS:528: DC%2BD1cXktVSgt74%3D 10.1159/000120630 18334851 (Pubitemid 351465602)
18. H. Narahara K. Fujitani H. Takiuchi N. Sugimoto K. Inoue N. Uedo, et al. 2008 Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer Oncology 74 37 41 1:CAS:528: DC%2BD1cXnvFSjs70%3D 10.1159/000138978 18544958 (Pubitemid 351915008)
19. K. Yoshida M. Ninomiya N. Takakura N. Hirabayashi W. Takiyama Y. Sato, et al. 2006 Phase II study of docetaxel and S-1 combination therapy for advanced or recurrent gastric cancer Clin Cancer Res 12 3402 3407 1:CAS:528: DC%2BD28XltFyis7k%3D 10.1158/1078-0432.CCR-05-2425 16740764
20. D. Cunningham N. Starling S. Rao T. Iveson M. Nicolson F. Coxon, et al. 2008 Capecitabine and oxaliplatin for advanced esophagogastric cancer N Engl J Med 358 36 46 1:CAS:528:DC%2BD1cXisFSktg%3D%3D 10.1056/NEJMoa073149 18172173
21. W. Koizumi H. Takiuchi Y. Yamada N. Boku N. Fuse K. Muro, et al. 2010 Phase II study of oxaliplatin plus S-1 as first-line treatment for advanced gastric cancer (G-SOX study) Ann Oncol 21 1001 1005 1:STN:280: DC%2BC3c3ptFyrtA%3D%3D 10.1093/annonc/mdp464 19875759
22. J. Chipponi M. Huguier D. Pezet N. Basso J.M. Hay P. Quandalle, et al. 2004 Randomized trial of adjuvant chemotherapy after curative resection for gastric cancer Am J Surg 187 440 445 1:CAS:528:DC%2BD2cXhvFaltb8%3D 10.1016/j.amjsurg.2003.12.014 15006580 (Pubitemid 38299517)
23. O. Bouché M. Ychou P. Burtin L. Bedenne M. Ducreux G. Lebreton, et al. 2005 Adjuvant chemotherapy with 5-fluorouracil and cisplatin compared with surgery alone for gastric cancer: 7-year results of the FFCD randomized phase III trial (8801) Ann Oncol 16 1488 1497 10.1093/annonc/mdi270 15939717 (Pubitemid 41226403)
24. M. Kochi M. Fujii N. Kanamori T. Kaiga T. Takahashi M. Kobayashi, et al. 2006 Neoadjuvant chemotherapy with S-1 and CDDP in advanced gastric cancer J Cancer Res Clin Oncol 132 781 785 1:CAS:528:DC%2BD28XhtVeqsb7O 10.1007/s00432-006-0126-4 16804723 (Pubitemid 44521453)
25. S. Satoh S. Hasegawa N. Ozaki H. Okabe G. Watanabe S. Nagayama, et al. 2006 Retrospective analysis of 45 consecutive patients with advanced gastric cancer treated with neoadjuvant chemotherapy using an S-1/CDDP combination Gastric Cancer 9 129 135 1:CAS:528:DC%2BD28XlsV2kurg%3D 10.1007/s10120-006-0369- 4 16767369